The Food Effect on Pharmacokinetics and Safety of Fixed-dose Combination of CJ-30056 in Healthy Male Subjects

Trial Profile

The Food Effect on Pharmacokinetics and Safety of Fixed-dose Combination of CJ-30056 in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Jan 2017

At a glance

  • Drugs Atorvastatin/metformin (Primary)
  • Indications Hyperlipidaemia; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors CJ HealthCare
  • Most Recent Events

    • 07 Mar 2015 Status changed from recruiting to completed as per the abstract presented at the 116th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
    • 18 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top